Valuation: Zynex, Inc.

Market Cap 3.83M 3.35M 3.09M 2.86M 5.38M 368M 5.48M 36.89M 14.47M 180M 14.38M 14.06M 620M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 33.23M 30.72M 28.38M 53.44M 3.65B 54.41M 366M 144M 1.79B 143M 140M 6.16B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-31.25%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.82
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap.
03-26Issuer sale

Director

80,001 0.2633%
03-26Issuer sale

Director

95,000 0.3126%
03-26Issuer sale

Director

102,000 0.3357%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-97.39%-99.41% 1.69M
+1.05%+3.38%+25.56%+0.89% 198B
-6.78%-11.19%-26.52%+7.20% 134B
-0.55%+2.50%+0.66%-17.25% 141B
-4.52%-5.89%-59.14%-19.61% 63.36B
-1.85%-4.99%+15.09%-3.52% 51.87B
-0.63%-0.18%-25.96%-33.61% 43.77B
+0.87%+3.10%+12.59%+12.90% 38.18B
+0.85%+0.39%+23.74%+39.01% 36.96B
-5.59%-4.98%-17.18%-24.64% 28.05B
Average -0.59%-4.47%-14.86%-13.80% 73.6B
Weighted average by Cap. -1.27%-2.03%-2.20%-3.99%

Financials

2023 2024
Net sales 184M 161M 149M 138M 259M 17.7B 264M 1.78B 697M 8.67B 692M 677M 29.85B 192M 168M 155M 144M 270M 18.48B 275M 1.85B 727M 9.05B 723M 707M 31.15B
Net income 9.73M 8.5M 7.86M 7.26M 13.68M 935M 13.93M 93.76M 36.79M 458M 36.56M 35.75M 1.58B 2.99M 2.62M 2.42M 2.23M 4.21M 288M 4.28M 28.84M 11.32M 141M 11.25M 11M 485M
Net Debt 31.59M 27.61M 25.52M 23.58M 44.4M 3.03B 45.2M 304M 119M 1.49B 119M 116M 5.12B 34.19M 29.88M 27.62M 25.52M 48.06M 3.28B 48.93M 329M 129M 1.61B 128M 126M 5.54B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock